Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
ESC: Finerenone Improves Outcomes in Patients with Mild-to-Moderate Kidney Disease and Diabetes
08/30/2021
FIGARO-DKD trial presented in a Hot Line Session today at ESC Congress 2021
FIGARO-DKD trial presented in a Hot Line Session today at ESC Congress 2021
FIGARO-DKD trial presented in a...
08/30/2021
Cath Lab Digest
News
Cardiovascular Institute of the South Celebrates Peripheral Artery Disease Awareness Month
08/27/2021
HOUMA, Louisiana (August 26, 2021). Pain or cramping in the legs may be a sign of a serious condition called peripheral artery disease (PAD). September is PAD Awareness Month, and Cardiovascular Institute of the South (CIS) urges our...
HOUMA, Louisiana (August 26, 2021). Pain or cramping in the legs may be a sign of a serious condition called peripheral artery disease (PAD). September is PAD Awareness Month, and Cardiovascular Institute of the South (CIS) urges our...
HOUMA, Louisiana (August 26,...
08/27/2021
Vascular Disease Management
News
ESC Congress: UK - Birmingham Scientists Discover New Piece of Clotting Puzzle
08/23/2021
August 23, 2021: University of Birmingham (UK) scientists have described a potential new target and strategy for anti-thrombotic therapy, in research that provides a new perspective on how blood clotting works in infectious and...
August 23, 2021: University of Birmingham (UK) scientists have described a potential new target and strategy for anti-thrombotic therapy, in research that provides a new perspective on how blood clotting works in infectious and...
August 23, 2021: University of...
08/23/2021
Cath Lab Digest

Advertisement

News
FastWave Medical, a Company Incubated by Partners of Big Sky Biomedical, Closes Series Pre-A Financing and Milestone-based Acquisition
08/23/2021
Minority investment will be used to accelerate development and global expansion of the company’s novel endovascular therapies for arterial disease, and includes acquisition obligations upon the completion of key technical, clinical, and...
Minority investment will be used to accelerate development and global expansion of the company’s novel endovascular therapies for arterial disease, and includes acquisition obligations upon the completion of key technical, clinical, and...
Minority investment will be...
08/23/2021
Cath Lab Digest
News
Society for Vascular Surgery Launches Vascular Verification Program to Enhance Quality Improvement
08/20/2021
The Society for Vascular Surgery (SVS), in partnership with the American College of Surgeons (ACS), today announced the future launch of a program to verify quality on the part of facilities that offer vascular care.
The Society for Vascular Surgery (SVS), in partnership with the American College of Surgeons (ACS), today announced the future launch of a program to verify quality on the part of facilities that offer vascular care.
The Society for Vascular Surgery...
08/20/2021
Cath Lab Digest
News
SVS: Hancock Jaffe Presents New Positive Two-Year VenoValve Data
08/19/2021
Two-year VenoValve® data shows average improvements in reflux, disease manifestations and pain, of 63%, 60%, and 93%, respectively.
Two-year VenoValve® data shows average improvements in reflux, disease manifestations and pain, of 63%, 60%, and 93%, respectively.
Two-year VenoValve® data shows...
08/19/2021
Vascular Disease Management

Advertisement

News
Siemens Healthineers AI-based COVID-19 Severity Algorithm Now Available
08/11/2021
The real-time, AI-based predictive tool was built using data from greater than 14,000 COVID-19 patients, with the goal of helping clinicians identify SARS-CoV-2 patients at risk of progressing to severe outcomes.1  The company plans...
The real-time, AI-based predictive tool was built using data from greater than 14,000 COVID-19 patients, with the goal of helping clinicians identify SARS-CoV-2 patients at risk of progressing to severe outcomes.1  The company plans...
The real-time, AI-based...
08/11/2021
Cath Lab Digest
News
FDA Grants Breakthrough Device Designation Status for Hancock Jaffe's VenoValve
08/05/2021
Goal of FDA Breakthrough Device Program is to speed up development by giving priority to devices that treat life-threatening or irreversibly debilitating conditions. VenoValve is a potential treatment for approximately 2.4 million U.S....
Goal of FDA Breakthrough Device Program is to speed up development by giving priority to devices that treat life-threatening or irreversibly debilitating conditions. VenoValve is a potential treatment for approximately 2.4 million U.S....
Goal of FDA Breakthrough Device...
08/05/2021
Vascular Disease Management
News
CIS Expands Management Services to Illinois Practice
08/02/2021
HOUMA, Aug, 2021- Cardiovascular Institute of the South (CIS), through its subsidiary company, Cardiovascular Logistics of Chicago, has entered into a management partnership with Midwest Cardiovascular Institute (MCI) based in the southwest...
HOUMA, Aug, 2021- Cardiovascular Institute of the South (CIS), through its subsidiary company, Cardiovascular Logistics of Chicago, has entered into a management partnership with Midwest Cardiovascular Institute (MCI) based in the southwest...
HOUMA, Aug, 2021- Cardiovascular...
08/02/2021
Vascular Disease Management

Advertisement

News
Cardinal Health Completes Sale of Cordis Business to Hellman & Friedman
08/02/2021
Cardinal Health and Hellman & Friedman (H&F) announced the completion of the previously announced sale of Cardinal Health's Cordis business to H&F.
Cardinal Health and Hellman & Friedman (H&F) announced the completion of the previously announced sale of Cardinal Health's Cordis business to H&F.
Cardinal Health and Hellman &...
08/02/2021
Cath Lab Digest

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use